PTGS2 and non-small cell lung carcinoma: Celecoxib in NSCLC: The roles of elevated COX-2 and CA-IX in NSCLC growth promotion, along with the potential benefit of celecoxib in NSCLC treatment, were recently reviewed [56,57,58].